Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:24 AM
Ignite Modification Date:
2025-12-25 @ 1:24 AM
NCT ID:
NCT07131293
Eligibility Criteria:
Inclusion Criteria:
* Patients of any age with a confirmed central lymphatic disorder, either in the context of CHD or as a primary lymphatic disorder, diagnosed by lymphatic imaging (e.g., T2-weighted MRL, DCMRL, or percutaneous lymphangiography under fluoroscopy).
* Patients who have undergone, or are undergoing, diagnostic lymphatic imaging and/or interventional procedures for their lymphatic disorder.
* Patients who are receiving, or have received, conservative (non-interventional) management for their lymphatic disorder.
Exclusion Criteria:
* Patients with isolated peripheral lymphatic disorders not involving the central lymphatic system.
* Patients with acute postoperative iatrogenic chylothorax (\<3-4 weeks duration and not requiring intervention).
* Patients without sufficient clinical documentation to confirm diagnosis, treatment, or follow-up.
* Patients who decline, or whose legal guardians decline, to provide informed consent (for prospective inclusion).
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT07131293
Study Brief:
Protocol Section:
NCT07131293